Cue Biopharma (CUE) Receivables (2019 - 2026)
Cue Biopharma's Receivables was $5.38 million in Q2 2026, up 910.7% from $532,000 a year earlier.
Powered by 
Analysis
Cue Biopharma (CUE) Receivables (2019 - 2026) Analysis & Trends
At the end of FY2025, Receivables at Cue Biopharma came in at $5.55 million, up 486.9% from FY2024.
- Receivables shows a five-year compound annual growth rate of 31.4% (FY2020 to FY2025).
- In earlier years, Receivables was $945,000 in FY2024 (-44.3%), $1.7 million in FY2023, $57,000 in FY2022 (-98.2%) and $3.14 million in FY2021 (+121.7%).
- Quarterly Receivables has moved between $57,000 (Q4 2022) and $5.55 million (Q4 2025) over five years.
- Compared with a year earlier, Receivables was higher in three of the last six quarters, with growth averaging 214.0%.
- The best year-over-year quarter for Receivables over five years was Q2 2026 (growth of 910.7%); the worst was Q4 2022 (a decline of 98.2%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.92 Bn | 1,105.50 Bn | 19.71 Bn | 23.48 Bn |
| 2 | Johnson & Johnson | 617.57 Bn | 536.10 Bn | 17.26 Bn | 19.05 Bn |
| 3 | AbbVie | 501.37 Bn | 474.48 Bn | 12.70 Bn | 13.82 Bn |
| 4 | Merck | 367.96 Bn | 322.33 Bn | 12.21 Bn | 12.56 Bn |
| 5 | Novartis Ag | 297.98 Bn | 261.97 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 261.45 Bn | 235.14 Bn | 12.86 Bn | 15.68 Bn |
| 7 | Amgen | 236.30 Bn | 191.70 Bn | 7.24 Bn | 10.23 Bn |
| 8 | Gilead Sciences | 190.27 Bn | 164.46 Bn | 6.22 Bn | 5.06 Bn |
| 9 | Pfizer | 169.65 Bn | 116.29 Bn | 10.94 Bn | 12.49 Bn |
| 10 | Cue Biopharma | 122.60 Mn | 31.87 Mn | - | 5.38 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.38 Mn |
| Dec 31, 2025 | 5.55 Mn |
| Sep 30, 2025 | 387,000.00 |
| Jun 30, 2025 | 532,000.00 |
| Dec 31, 2024 | 945,000.00 |
| Sep 30, 2024 | 3.15 Mn |
| Jun 30, 2024 | 1.85 Mn |
| Mar 31, 2024 | 1.40 Mn |
| Dec 31, 2023 | 1.70 Mn |
| Sep 30, 2023 | 1.66 Mn |
| Jun 30, 2023 | 1.14 Mn |
| Mar 31, 2023 | 196,000.00 |
| Dec 31, 2022 | 57,000.00 |
| Sep 30, 2022 | 796,000.00 |
| Jun 30, 2022 | 736,000.00 |
| Mar 31, 2022 | 925,000.00 |
| Dec 31, 2021 | 3.14 Mn |
| Sep 30, 2021 | 771,000.00 |
| Jun 30, 2021 | 1.90 Mn |
| Mar 31, 2021 | 1.41 Mn |
API Access
Cue Biopharma Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=CUE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "CUE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=CUE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();